Published in Lancet on February 02, 2013
Modeling infectious disease dynamics in the complex landscape of global health. Science (2015) 1.37
Viewpoint: Re-instating a 'public health' system under universal health care in India. J Public Health Policy (2014) 1.07
Re-evaluation of microscopy confirmed Plasmodium falciparum and Plasmodium vivax malaria by nested PCR detection in southern Ethiopia. Malar J (2014) 1.01
After 2015: infectious diseases in a new era of health and development. Philos Trans R Soc Lond B Biol Sci (2014) 0.94
Future declines of coronary heart disease mortality in England and Wales could counter the burden of population ageing. PLoS One (2014) 0.89
Factors responsible for the emergence of arboviruses; strategies, challenges and limitations for their control. Emerg Microbes Infect (2015) 0.89
Vector control programs in Saint Johns County, Florida and Guayas, Ecuador: successes and barriers to integrated vector management. BMC Public Health (2014) 0.81
Evaluation of an urban phase of the specialized care program for diabetes in iran: providers' perspectives. Int J Prev Med (2014) 0.81
The limits of medical interventions for the elimination of preventable blindness. Trop Med Health (2014) 0.80
Sloth hair as a novel source of fungi with potent anti-parasitic, anti-cancer and anti-bacterial bioactivity. PLoS One (2014) 0.80
Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population. Int J Parasitol (2016) 0.76
Continued vigilance - development of an online evaluation tool for assessing preparedness of medical facilities for biological events. Front Public Health (2014) 0.75
RETROSPECTIVE STUDY OF MEASURING TUBERCULOSIS THERAPY COMPLIANCE: GREECE AS A HOST COUNTRY FOR VULNERABLE POPULATIONS BEFORE AND DURING THE FINANCIAL CRISIS. Mater Sociomed (2015) 0.75
Reconstruction of diaminopimelic acid biosynthesis allows characterisation of Mycobacterium tuberculosis N-succinyl-L,L-diaminopimelic acid desuccinylase. Sci Rep (2016) 0.75
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
Control of neglected tropical diseases. N Engl J Med (2007) 14.49
Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89
Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis (2007) 10.66
Soil-transmitted helminth infections: updating the global picture. Trends Parasitol (2003) 9.33
Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet (2010) 7.07
Rescuing the bottom billion through control of neglected tropical diseases. Lancet (2009) 6.60
The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med (2008) 6.41
Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA (2005) 5.39
A research agenda to underpin malaria eradication. PLoS Med (2011) 5.34
International standards for tuberculosis care. Lancet Infect Dis (2006) 4.67
Evaluation of reported malaria chemoprophylactic failure among travelers in a US University Exchange Program, 2002. Clin Infect Dis (2004) 4.33
Insecticide-treated net ownership and usage in Niger after a nationwide integrated campaign. Trop Med Int Health (2008) 4.26
The threat of artemisinin-resistant malaria. N Engl J Med (2011) 4.15
Increasing transparency in partnerships for health--introducing the Green Light Committee. Trop Med Int Health (2002) 3.59
Strengthening the policy setting process for global malaria control and elimination. Malar J (2012) 3.53
Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis (2006) 3.32
The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg (2004) 3.00
Placental malaria increases malaria risk in the first 30 months of life. Clin Infect Dis (2008) 2.69
Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science (2002) 2.65
Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis (2012) 2.55
Controlling soil-transmitted helminthiasis in pre-school-age children through preventive chemotherapy. PLoS Negl Trop Dis (2008) 2.55
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis (2006) 2.48
Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis (2006) 2.46
Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res (2011) 2.45
Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Saf (2007) 2.30
Africa is desperate for praziquantel. Lancet (2010) 2.20
Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis (2004) 2.20
Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control. Int J Parasitol (2004) 2.14
Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol (2003) 2.13
Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data. Lancet Infect Dis (2013) 1.96
The WHO policy package to combat antimicrobial resistance. Bull World Health Organ (2011) 1.93
Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso. Am J Trop Med Hyg (2006) 1.92
Scale-up of HIV treatment through PEPFAR: a historic public health achievement. J Acquir Immune Defic Syndr (2012) 1.78
Malaria surveillance - United States, 2005. MMWR Surveill Summ (2007) 1.75
Evaluation of a malaria rapid diagnostic test for assessing the burden of malaria during pregnancy. Am J Trop Med Hyg (2004) 1.74
Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet (2010) 1.69
Malaria surveillance--United States, 2004. MMWR Surveill Summ (2006) 1.66
Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia. PLoS One (2012) 1.66
Reconsidering the underestimated burden caused by neglected tropical diseases. Trends Parasitol (2006) 1.65
Helminthic infections. BMJ (2003) 1.54
Intervention for the control of soil-transmitted helminthiasis in the community. Adv Parasitol (2006) 1.52
Heavy cryptosporidial infections in children in northeast Brazil: comparison of Cryptosporidium hominis and Cryptosporidium parvum. Trans R Soc Trop Med Hyg (2006) 1.49
Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupéla District, Burkina Faso. Clin Infect Dis (2003) 1.47
Control of human fascioliasis by selective chemotherapy: design, cost and effect of the first public health, school-based intervention implemented in endemic areas of the Nile Delta, Egypt. Trans R Soc Trop Med Hyg (2005) 1.46
Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis (2004) 1.45
Neglected tropical diseases and the Global Fund. Lancet (2009) 1.44
The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century. Infect Dis Clin North Am (2002) 1.39
A comparison of methods for detecting the eggs of Ascaris, Trichuris, and hookworm in infant stool, and the epidemiology of infection in Zanzibari infants. Am J Trop Med Hyg (2007) 1.39
The "vertical-horizontal" debates: time for the pendulum to rest (in peace)? Bull World Health Organ (2007) 1.33
Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach. BMC Public Health (2012) 1.32
Intermittent preventive therapy for malaria: progress and future directions. Curr Opin Infect Dis (2007) 1.31
Giardia duodenalis assemblage, clinical presentation and markers of intestinal inflammation in Brazilian children. Trans R Soc Trop Med Hyg (2008) 1.30
Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis (2007) 1.29
Progress towards malaria control targets in relation to national malaria programme funding. Malar J (2013) 1.28
New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes. Curr Opin Pulm Med (2010) 1.27
Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings. Malar J (2009) 1.26
Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study. PLoS Negl Trop Dis (2008) 1.26
Severe cutaneous reactions to sulfadoxine-pyrimethamine and trimethoprim-sulfamethoxazole in Blantyre District, Malawi. Am J Trop Med Hyg (2006) 1.24
Malaria surveillance--United States, 2001. MMWR Surveill Summ (2003) 1.24
Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: identifying best practices to roll out programs at national scale. Am J Trop Med Hyg (2012) 1.23
The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa. PLoS One (2010) 1.22
Hyperendemic fascioliasis associated with schistosomiasis in villages in the Nile Delta of Egypt. Am J Trop Med Hyg (2003) 1.22
Malaria surveillance--United States, 2003. MMWR Surveill Summ (2005) 1.21
Congenital malaria in the United States: a review of cases from 1966 to 2005. Arch Pediatr Adolesc Med (2007) 1.20
Tuberculosis and HIV: time for an intensified response. Lancet (2010) 1.19
Planning to improve global health: the next decade of tuberculosis control. Bull World Health Organ (2007) 1.19
Is the exclusion of children under 24 months from anthelmintic treatment justifiable? Trans R Soc Trop Med Hyg (2002) 1.18
Is Option B+ the best choice? Lancet (2013) 1.18
Development of the egg hatch assay for detection of anthelminthic resistance in human hookworms. Int J Parasitol (2005) 1.18
Soil-transmitted helminthiasis in Myanmar and approximate costs for countrywide control. Trop Med Int Health (2004) 1.16
Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial. PLoS One (2010) 1.14
Innovative device methods for adult medical male circumcision for HIV prevention: lessons from research. J Acquir Immune Defic Syndr (2013) 1.14
The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realities. Curr Opin HIV AIDS (2013) 1.14
Patients with previously treated tuberculosis no longer neglected. Clin Infect Dis (2006) 1.13
Malaria vaccine technology roadmap. Lancet (2013) 1.12
Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples. J Acquir Immune Defic Syndr (2013) 1.12
Cost-effectiveness of generic antiretroviral therapy. Ann Intern Med (2013) 1.11
The new Stop TB Strategy and the Global Plan to Stop TB, 2006-2015. Bull World Health Organ (2007) 1.05
Pre-departure and post-arrival management of P. falciparum malaria in refugees relocating from sub-Saharan Africa to the United States. Am J Trop Med Hyg (2008) 1.04
Scale up: meeting targets in global tuberculosis control. Lancet (2004) 1.04
Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis. Lancet (2004) 1.04
Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance. PLoS One (2010) 1.04
The control of human (neuro)cysticercosis: which way forward? Acta Trop (2003) 1.03
Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali. Malar J (2009) 1.01
Facing extensively drug-resistant tuberculosis--a hope and a challenge. N Engl J Med (2008) 1.00
Low-dose daily iron supplementation for 12 months does not increase the prevalence of malarial infection or density of parasites in young Zanzibari children. J Nutr (2004) 1.00
How much malaria occurs in urban Luanda, Angola? A health facility-based assessment. Am J Trop Med Hyg (2009) 1.00
A Global Fund to Fight Neglected Tropical Diseases: is the G8 Hokkaido Toyako 2008 Summit ready? PLoS Negl Trop Dis (2008) 0.99
A road map to control malaria, tuberculosis, and human immunodeficiency virus/AIDS. Arch Intern Med (2009) 0.99
Evaluation of the efficacy of pyrantel-oxantel for the treatment of soil-transmitted nematode infections. Trans R Soc Trop Med Hyg (2003) 0.98
HIV treatment as prevention: how scientific discovery occurred and translated rapidly into policy for the global response. Health Aff (Millwood) (2012) 0.98
What research is needed to stop TB? Introducing the TB Research Movement. PLoS Med (2011) 0.97
Malaria scale-up progress: is the glass half-empty or half-full? Lancet (2008) 0.96
Performance of the Haemoglobin Colour Scale in diagnosing severe and very severe anaemia. Trop Med Int Health (2003) 0.96
Rebuttal: Evidence and uncertainties. Int J Tuberc Lung Dis (2002) 0.95
Genetic diversity of HIV-1 in western Kenya: subtype-specific differences in mother-to-child transmission. AIDS (2003) 0.94
Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey. Antimicrob Agents Chemother (2013) 0.93